Edition:
United States

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
18 Jan 2019
Change (% chg)

$0.05 (+2.53%)
Prev Close
$1.98
Open
$2.00
Day's High
$2.04
Day's Low
$1.98
Volume
1,855
Avg. Vol
14,595
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 0.77
Market Cap(Mil.): $28.02
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.12 -- --
ROI: -9.11 0.60 13.80
ROE: -11.67 -2.18 15.29

Earnings vs. Estimates